Juno raises $318.7M in follow-on, private placement

Cell therapy company Juno Therapeutics Inc. (NASDAQ:JUNO) raised $287.6 million through the sale of 7 million shares at $41 in a follow-on underwritten by Morgan Stanley, JPMorgan, Barclays, Leerink, Wells Fargo, Raymond James and Wedbush PacGrow. The figure includes the sale of a 915,000 share overallotment on Sept. 26.

Concurrently, the company raised $31.1 million through the sale of 758,327 shares at $41 in a private placement with a subsidiary of Celgene Corp. (NASDAQ:CELG)...